Petter Portin, of the University of Turku, Finland, has been forced to retract four papers because they were duplicates of work he had already published.
Two of those retractions appear in the February 2011 issue of Hereditas. Here’s one retraction notice (link added):
In November, we reported on two retractions in Cell and the Journal of Molecular Biology involving misconduct in the lab of biochemist Carsten Carlberg, of the University of Eastern Finland, in Kuopio.
Carlberg also holds an appointment in computational biology at the University of Luxembourg, which last year launched an investigation — at his behest, he says — into the case. Well, the officials in Luxembourg finally have spoken, and Carlberg, it seems, may soon be out of his job there, the Tageblatt newspaper reports.
Carlberg, to our knowledge, has never been accused of ethical violations in the case, and the inquiry didn’t change that. Rather, the bad actor appears to be his former post-doc graduate student in Finland, Tatjana Degenhardt. But the University of Luxembourg may seek to dismiss Carlberg after concluding that, as the senior author of the two retracted articles, he bore responsibility for the validity of the results and, by implication, the deception.
Retraction Watch readers may have been following the case of Silvia Bulfone-Paus, whose lab has been forced to retract 12 papers amid allegations of scientific misconduct. As is often true in such cases, the story doesn’t end with those retractions. We’ve just become aware of a fascinating exchange in March and April between Bulfone-Paus’s supporters and her home institution, Germany’s Research Center Borstel.
First, some background: Karin Wiebauer, a former post-doc in Bulfone-Paus’s lab, flagged the potential misconduct, in great detail, for Bulfone-Paus in a November 2009 email. (In fact, she had brought it to her attention years earlier.) But Bulfone-Paus did not tell Borstel officials about the allegations until late February 2010. Borstel’s investigation into Bulfone-Paus’s lab began in July 2010.
Once that began, a person referring to himself as “Marco Berns” began emailing officials, journalists, and others about the situation. Nature called that move a “smear campaign,” and the emails “libellous,” but in retrospect they — and Wiebauer’s analysis — appear to have been spot-on, based on the eventual report of the Borstel committee. That report — which found data manipulation by two of Bulfone-Paus’s post-docs — led the institute’s Scientific Advisory Board to ask for Bulfone-Paus’s resignation. She only tendered that a month later, after more pressure.
A controversial study of how relationships between climate change scientists may affect the field, and that has been dogged by charges of plagiarism, will be retracted, USA Today reports.
We conjecture that certain styles of co-authorship lead to the possibility of group-think, reduced creativity, and the possibility of less rigorous reviewing processes.
Last month, we brought you news of two retractions in math journals for duplicate publication and apparent guest authorship. Last week, we learned that the lead author of one of those papers, Amir Mahmood, has retracted another paper, this one in Nonlinear Analysis: Real World Applications.
According to the retraction notice, the paper was an “accidental duplication of an article that has already been published” in Communications in Nonlinear Science and Numerical Simulation.
The papers share two authors: Mahmood, of the department of mathematics at COMSATS Institute of Information Technology and the Abdus Salam School of Mathematical Sciences of GC University, both in Lahore, Pakistan; and N.A. Khan, of the University of Karachi’s math department. Khan was also on one of the two papers we wrote about last month, but not the one Mahmood co-authored. Those two papers’ shared author was M. Jamil.
Mahmood told Retraction Watch by email that the papers are not duplicates, and that the journal editors could not explain to him why they were.
Readers may recall a recent post on a study purporting to show that one of the best insurance policies against a retraction is to employ a medical writer. Well, a group of Iranian surgeons did just that. How’d it work out for them?
Of course, since you’re reading about this on Retraction Watch, you already know the answer to that one, don’t you?
The World Journal of Surgery has retracted a 2010 article written by hired guns who apparently decided to perform wordthievery rather than wordsmithery.
At a time when you can set up a Google alert to find out when your name appears anywhere on the Web — not that we’d know, of course — it puzzles us that some researchers are trying to get away with using others’ names on papers without their knowledge.
But they’re not just trying. Our recent experience suggests they’re actually getting away with it and seeing those papers in print. We’ve found at least six cases of that in the past few months. Of course, some eventually get caught.
have recently discovered that the cell lines used in their paper were inadvertently misidentified. The cell lines utilized in the paper have now been found to contain the bcr/abl translocation and most likely represent the K562 CML cell line, instead of MMS1 and RPM1 myeloma cell lines. Due to this issue, the relevance of the findings to myeloma and thus, the conclusions of the paper, are not supported by the data. The authors apologize to the readers, reviewers, and editors of Blood for publishing these erroneous data.
That seems straightforward enough, and we couldn’t find any evidence that this problem affected other publications.
For those Retraction Watch readers who have been following the case of Anil Potti — who has now retracted four papers — Keith Baggerly’s name will likely be familiar. Baggerly is the bioinformatician at M.D. Anderson in Houston who has been publicly questioning, in letters, papers, and The Cancer Letter, work by Potti et. al.
Yesterday, Baggerly gave a keynote at the Council of Science Editors meeting in Baltimore. It was a fascinating — and riveting — walk through how, after a group at M.D. Anderson asked him and his team to evaluate the Potti group’s tools for predicting whether given patients would respond to different chemotherapies, Baggerly’s group unraveled the Potti research.
In his talk, Baggerly demonstrated all of the mislabeling and other easily recognized errors his team found when they sifted through the raw data. And yet there were a number of wince-inducing moments in which Baggerly described the cool reception he had from several journals.
There have been a lot of calls recently that journals should require that authors deposit their data. There’s none more powerful than when they come at the end of a talk showing how that could have stopped a faulty clinical trial from ever starting.
Baggerly told Retraction Watch he just wants this story to get the widest attention possible, so he was glad to allow us to post his slides. They get appropriately technical, given the crowd, but it’s worth it. You can follow a very unofficial and rough transcript at this Twitter search, since Ivan live-tweeted the talk. Or just click over to the slideshow here.
Petter Portin, of the University of Turku, Finland, has been forced to retract four papers because they were duplicates of work he had already published.
